Literature DB >> 2853273

In vivo and in vitro models of demyelinating disease. XVII. The infectious process in athymic rats inoculated with JHM virus.

O Sorensen1, A Saravani, S Dales.   

Abstract

Wistar Lewis (WL), Long Evans (LE) and other rat strains develop complete resistance to CNS disease when inoculated intracerebrally with murine hepatitis JHM virus (JHMV) after the 10th day of age. Two types of studies were conducted to ascertain the involvement of the cellular immune system in development of resistance. Immunosuppression of WL rats with cyclosporin A (CsA) following onset of the age-related resistance demonstrated that this drug was partially able to abrogate resistance. In the other studies nude (rnu/rnu) rats, their heterozygous (rnu/+) litter mates and genetically related LE rats of various ages were challenged with JHMV. The rnu/+ and LE animals became completely resistant before the age of weaning, whereas some rnu/rnu rats, challenged as late as 70 days of age, showed disease symptoms--albeit after a long latent period. These observations indicated that the cellular immune system plays an important role in suppressing the disease process in the CNS. When the infection of nude rats was initiated on or after the 15th day of life, the histological lesions were generally small and present in both grey and white matter but were seldom seen in the spinal cord. Mononuclear infiltrates were evident throughout the CNS. In some nude rats there was massive mononuclear cell infiltration towards the meningies and into ventricular spaces. By contrast in mu/+, LE and WL rats with late-onset disease symptoms, demyelinating-type lesions were confined to the white matter and only minor infiltration of mononuclear cells was evident. JHMV RNA was detectable by dot-blotting analysis in the CNS of both paralysed and asymptomatic rnu/rnu and rnu/+ rats, but less RNA was usually detected in heterozygous animals. In-situ hybridization with cDNA probes for JHMV RNA showed that neurons in the hippocampus and cerebellum, as well as cells in the white matter, were frequently infected. The present data indicate that in the rat T cells have an important function in maintaining resistance to the JHMV related disease process. However, even without a functional T cell compartment nude rats challenged after 15 days of age did not develop an acute encephalitis, suggesting that an age-dependent, non-immunological mechanism is also involved in restricting the spread of infection. It is possible that resistance in euthymic rats sets in because: (1) at the time of weaning the CNS matures, so that the number of targets available for infection is reduced, (2) T cells prevent the late-onset disease by clearing persistent, low grade infections from the CNS.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2853273      PMCID: PMC7134691          DOI: 10.1016/0882-4010(87)90100-8

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  14 in total

1.  Corona virus induced subacute demyelinating encephalomyelitis in rats: a morphological analysis.

Authors:  K Nagashima; H Wege; R Meyermann; V ter Meulen
Journal:  Acta Neuropathol       Date:  1978-10-13       Impact factor: 17.088

2.  In vivo and in vitro models of demyelinating diseases. IV. Isolation of Hallé measles virus-specific RNA from BGMK cells and preparation of complementary DNA.

Authors:  M B Coulter-Mackie; W C Bradbury; S Dales; W F Flintoff; V L Morris
Journal:  Virology       Date:  1980-04-30       Impact factor: 3.616

3.  The athymic nude rat. III. Natural cell-mediated cytotoxicity.

Authors:  W H de Jong; P A Steerenberg; P S Ursem; A D Osterhaus; J G Vos; E J Ruitenberg
Journal:  Clin Immunol Immunopathol       Date:  1980-10

4.  In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice.

Authors:  O Sorensen; R Dugre; D Percy; S Dales
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

5.  In vivo and in vitro models of demyelinating diseases. III. JHM virus infection of rats.

Authors:  O Sorensen; D Perry; S Dales
Journal:  Arch Neurol       Date:  1980-08

6.  Cellular immune response in rnu/rnu rats. I. Lectin responsiveness and IL-2 production kinetics of natural cytotoxicity and spleen-cell surface marker expression.

Authors:  A Sfaksi; M Bonneville; J P Soulillou
Journal:  Immunology       Date:  1985-08       Impact factor: 7.397

7.  In vivo and in vitro models of demyelinating disease: JHM virus in the rat central nervous system localized by in situ cDNA hybridization and immunofluorescent microscopy.

Authors:  O Sorensen; S Dales
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

8.  Effects of immunologically induced growth hormone deficiency on myelinogenesis in developing rat cerebrum.

Authors:  E W Pelton; R E Grindeland; E Young; N H Bass
Journal:  Neurology       Date:  1977-03       Impact factor: 9.910

9.  In vivo and in vitro models of demyelinating disease. XI. Tropism and differentiation regulate the infectious process of coronaviruses in primary explants of the rat CNS.

Authors:  S Beushausen; S Dales
Journal:  Virology       Date:  1985-02       Impact factor: 3.616

10.  In vivo and in vitro models of demyelinating diseases. XV. Differentiation influences the regulation of coronavirus infection in primary explants of mouse CNS.

Authors:  G A Wilson; S Beushausen; S Dales
Journal:  Virology       Date:  1986-06       Impact factor: 3.616

View more
  14 in total

1.  In vivo and in vitro models of demyelinating disease: activation of the adenylate cyclase system influences JHM virus expression in explanted rat oligodendrocytes.

Authors:  S Beushausen; S Narindrasorasak; B D Sanwal; S Dales
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system.

Authors:  M A Sussman; R A Shubin; S Kyuwa; S A Stohlman
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

3.  Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain.

Authors:  S A Stohlman; S Kyuwa; J M Polo; D Brady; M M Lai; C C Bergmann
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

4.  In vivo and in vitro models of demyelinating disease: efficiency of virus spread and formation of infectious centers among glial cells is genetically determined by the murine host.

Authors:  G A Wilson; S Dales
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

5.  Infection by coronavirus JHM of rat neurons and oligodendrocyte-type-2 astrocyte lineage cells during distinct developmental stages.

Authors:  J M Pasick; S Dales
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

6.  Virus-induced demyelination in nude mice is mediated by gamma delta T cells.

Authors:  Ajai A Dandekar; Stanley Perlman
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

7.  Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system.

Authors:  S A Stohlman; C C Bergmann; R C van der Veen; D R Hinton
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  Deficient incorporation of spike protein into virions contributes to the lack of infectivity following establishment of a persistent, non-productive infection in oligodendroglial cell culture by murine coronavirus.

Authors:  Yin Liu; Werner Herbst; Jianzhong Cao; Xuming Zhang
Journal:  Virology       Date:  2010-10-28       Impact factor: 3.616

9.  Rapid isolation of morbillivirus nucleocapsid for genomic RNA cDNA cloning and the production of specific core protein antisera.

Authors:  M Oglesbee; L Tatalick; S Ringler; J Rice; S Krakowka
Journal:  J Virol Methods       Date:  1989-06       Impact factor: 2.014

Review 10.  Pathogenesis of virus-induced demyelination.

Authors:  J K Fazakerley; M J Buchmeier
Journal:  Adv Virus Res       Date:  1993       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.